Esperion Therapeutics, Inc. short interest in 2018
In 2018, Esperion Therapeutics, Inc.'s disclosed short interest ran from 10.29% of shares outstanding on 12 Jan 2018 to 16.63% on 31 Dec 2018, a change of +6.34 percentage points. The year's high was 27.11% on 15 Jun 2018 and its low 10.02% on 15 Feb 2018, averaging 18.96% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.47 days on 14 Sep 2018. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 10.29% (12 Jan 2018)
- End of year
- 16.63% (31 Dec 2018)
- Change
- +6.34 pp
- High
- 27.11% (15 Jun 2018)
- Low
- 10.02% (15 Feb 2018)
- Average
- 18.96%
- Highest days to cover
- 14.47 (14 Sep 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 10.29% | 5.45 | |
| 31 Jan 2018 | 12.67% | 5.33 | |
| 15 Feb 2018 | 10.02% | 4.16 | |
| 28 Feb 2018 | 10.16% | 4.76 | 10-K filed, results (8-K) |
| 15 Mar 2018 | 10.89% | 3.36 | |
| 29 Mar 2018 | 13.05% | 5.29 | |
| 13 Apr 2018 | 13.07% | 6.37 | |
| 30 Apr 2018 | 14.88% | 9.88 | |
| 15 May 2018 | 19.26% | 1.26 | 10-Q filed, results (8-K) |
| 31 May 2018 | 26.30% | 6.33 | |
| 15 Jun 2018 | 27.11% | 7.93 | |
| 29 Jun 2018 | 25.39% | 9.74 | |
| 13 Jul 2018 | 24.88% | 6.78 | |
| 31 Jul 2018 | 26.67% | 13.28 | |
| 15 Aug 2018 | 22.99% | 11.40 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 22.80% | 9.29 | |
| 14 Sep 2018 | 23.29% | 14.47 | |
| 28 Sep 2018 | 21.35% | 9.80 | |
| 15 Oct 2018 | 19.05% | 10.24 | |
| 31 Oct 2018 | 21.26% | 5.40 | |
| 15 Nov 2018 | 23.71% | 6.27 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 18.93% | 8.39 | |
| 14 Dec 2018 | 20.46% | 10.51 | |
| 31 Dec 2018 | 16.63% | 6.84 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.